Skip to main content

Table 3 Frequencies of secondary outcomes of the index pregnancy in each treatment group

From: Progesterone therapy for prevention of recurrent spontaneous preterm birth in a minority patient population: a retrospective study

Secondary Outcomes

Total (N = 637)

Any Progesterone (N = 353)

ap-value

17-OHPC (N = 296)

bp-value

Vaginal Progesterone (N = 42)

cp-value

No treatment (N = 287)

Recurrent preterm birth (20 0/7- < 37 weeks)

161 (25.3)

99 (27.7)

0.1453

86 (29.1)

0.07666

6 (14.3)

0.3254

64 (22.3)

Recurrent preterm birth (20 0/7—< 34 weeks)

59 (9.3)

40 (11.4)

0.04774

35 (11.8)

0.04297

3 (7.1)

1

19 (6.6)

Recurrent preterm birth (20 0/7—< 28 weeks)

21 (3.3)

14 (4.0)

0.371

13 (4.4)

0.2857

0 (0.0)

0.6523

7 (2.5)

Recurrent preterm birth (20 0/7—< 24 weeks)

8 (1.3)

4 (1.1)

1

0 (0.0)

1

0 (0.0)

0.9854

8 (2.3)

Latency (days)

 

50.2 ± 38.97

< 0.001

49.6 ± 39.4

< 0.001

51.7 ± 37.4

< 0.001

32.98 ± 37.9

Second trimester loss (< 20 weeks)

8 (1.2)

0 (0.0)

0.005563

0 (0.0)

0.0112

0 (0.0)

0.5761

8 (1.2)

First trimester loss (< 14 weeks)

0 (0.0)

0 (0.0)

0 (0.0)

0 (0.0)

0 (0.0)

Preeclampsia

69 (10.8)

34 (9.8)

0.3722

27 (9.1)

0.2585

6 (14.3)

0.8885

35 (12.2)

Gestational age at delivery (weeks)

37.0 ± 3.9

37.0 ± 3.4

0.9542

36.9 ± 3.5

0.8699

37.9 ± 2.0

0.1856

36.9 ± 4.5

Birthweight (grams)

2991.7 ± 731.2

2956.8 ± 728.7

0.2344

2972.6 ± 723.4

0.3395

2895.4 ± 699.6

0.2601

3031.0 ± 729.7

1 min Apgar (0–9)

7.7 ± 1.9

7.7 ± 1.9

0.5895

7.6 ± 1.9

0.3538

8.2 ± 0.8

0.1332

7.8 ± 1.9

5-min Apgar (0–9)

8.5 ± 1.4

8.6 ± 1.3

0.9179

8.5 ± 1.4

0.8385

8.9 ± 0.4

0.1476

8.5 ± 1.6

Neonatal demise (demise within 30 DOL)

11 (1.7)

7 (2.0)

0.7728

7 (2.4)

0.5824

0 (0.0)

0.9831

4 (1.4)

Cesarean delivery

224 (35.3)

128 (36.9)

0.3703

110 (37.1)

0.3473

12 (28.6)

0.6509

95 (33.1)

NICU admission

181 (28.5)

108 (31.1)

0.08675

94 (31.8)

0.0715

11 (26.2)

0.9417

72 (25.1)

Respiratory Distress Syndrome

32 (5.0)

23 (3.6)

0.2602

18 (6.8)

0.2735

2 (4.8)

1

11 (3.0)

Bronchopulmonary Dysplasia

7 (1.1)

4 (0.6)

1

3 (1.0)

1

0 (0.0)

1

3 (1.0)

Grade III-IV Intraventricular hemorrhage

2 (0.3)

1 (0.2)

1

1 (0.3)

1

0 (0.0)

1

1 (0.3)

Necrotizing Enterocolitis

1 (0.2)

1 (0.2)

1

1 (0.3)

1

0 (0.0)

0 (0.0)

Sepsis

5 (0.8)

4 (0.6)

1

3 (1.0)

1

0 (0.0)

1

2 (0.7)

Length of NICU stay (days)

6.8 ± 18.3

7.7 ± 19.2

0.3139

8.2 ± 19.7

0.2002

2.2 ± 6.1

0.1998

5.9 ± 17.4

Length of hospital stay (days)

4.1 ± 4.0

4.3 ± 4.8

0.05204

4.2 ± 4.2

0.07702

3.9 ± 2.6

0.728

3.7 ± 2.5

  1. ap-value compares any progesterone to no treatment
  2. bp-value compares 17-OHPC to no treatment
  3. cp-value compares vaginal progesterone to no treatment